Ozempic-like meds linked to higher risk of pancreatitis, 'stomach paralysis' than other weight-loss drugs

GLP-1 agonists like Ozempic come with a higher risk of severe GI issues than a different common weight-loss drug does.

Related Keywords

United Kingdom ,British ,Mohit Sodhi ,University Of British Columbia ,British Columbia ,Pharmetrics Plus ,